Linabite M 2.5/500 Tablet 10

Linabite M 2.5/500 Tablet 10 interacts with the following medicines:

• Carbonic Anhydrase Inhibitors: Medicines like topiramate and zonisamide may increase the risk of lactic acidosis when taken with Linabite M 2.5/500 Tablet 10.

• Cationic Medicines: Medications such as cimetidine and ranolazine may compete with metformin for elimination through the kidneys, potentially increasing metformin levels in the blood.

• Antiviral Medicines: Medicines like dolutegravir may affect how metformin works in your body, potentially leading to changes in blood sugar control.

Linabite M 2.5/500 Tablet 10 interacts with the following diseases:

• Kidney Disease: Patients with severe kidney problems (eGFR below 30 mL/min) should not take this medicine, as it increases the risk of lactic acidosis.

• Liver disease: This medicine should be used cautiously in patients with liver problems, as it may affect how the medicine is processed.

• Pancreatitis: Patients with a history of pancreatitis should use this medicine cautiously, as linagliptin may increase the risk of pancreatic inflammation.

• Heart Failure: People with heart failure may have an increased risk of lactic acidosis when taking metformin-containing medicines.

The daily dose of Linabite M 2.5/500 Tablet 10 should be taken as prescribed by your doctor. The dosage may change based on individual factors such as your response to treatment. It is important to follow the prescribed dosage without altering it.

Overdosing on Linabite M 2.5/500 Tablet 10 may cause stomach problems, headache, and low blood sugar (hypoglycaemia). You might feel dizzy, sweaty, confused, or unusually tired. Contact your doctor if you suspect an overdose.

If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed one and resume your regular schedule. Never take a double dose to make up for the missed one.